Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -9.23% is 50% above its 5-year average of -18.44%, near the high end of its 5-year range (-147.49%–1.16%).
As of the fiscal period ended Sunday, May 31, 2026. 91.62% above its 12-month average of -110.20%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q4 FY2026 (2026-05-31): -9.23%.
RETURN ON EQUITY (ROE)
-9.23%
RETURN ON EQUITY (ROE) AVG TTM
-110.20%
RETURN ON EQUITY (ROE) AVG 3Y
-57.04%
RETURN ON EQUITY (ROE) AVG 5Y
-18.44%
RETURN ON EQUITY (ROE) AVG 10Y
-14.09%
RETURN ON EQUITY (ROE) AVG 15Y
-26.34%
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+91.62%
CURRENT VS 3Y AVG
+83.81%
CURRENT VS 5Y AVG
+49.93%
CURRENT VS 10Y AVG
+34.45%
CURRENT VS 15Y AVG
+64.95%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
+78.02%
vs the sector median at left
Tilray Brands, Inc.
Market Cap
$425.52M
Return on Equity (ROE)
-9.23%
TTM Avg
-110.20%
3Y Avg
-57.04%
5Y Avg
-18.44%
Market Cap
$425.13M
Return on Equity (ROE)
-1721.80%
TTM Avg
-73.40%
3Y Avg
-45.77%
5Y Avg
-18.46%
Market Cap
$430.46M
Return on Equity (ROE)
-70.24%
TTM Avg
-381.56%
3Y Avg
-217.03%
5Y Avg
-155.40%
Market Cap
$429.88M
Return on Equity (ROE)
-6.60%
TTM Avg
-10.82%
3Y Avg
-11.36%
5Y Avg
-7.59%
Market Cap
$420.34M
Return on Equity (ROE)
-15.33%
TTM Avg
-56.08%
3Y Avg
-39.28%
5Y Avg
-33.86%
Market Cap
$420.28M
Return on Equity (ROE)
-65.99%
TTM Avg
-51.25%
3Y Avg
-81.12%
5Y Avg
-81.12%
Market Cap
$436.92M
Return on Equity (ROE)
-38.32%
TTM Avg
-35.34%
3Y Avg
12.60%
5Y Avg
10.50%
Market Cap
$438.56M
Return on Equity (ROE)
-0.01%
TTM Avg
-61.70%
3Y Avg
-96.25%
5Y Avg
-81.28%
Market Cap
$414.18M
Return on Equity (ROE)
-121.12%
TTM Avg
180.84%
3Y Avg
-1331.02%
5Y Avg
-839.91%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | $425.52M | -9.23% | -110.20% | -57.04% | -18.44% |
| ARS Pharmaceuticals, Inc. (SPRY)vs › | $425.13M | -1721.80% | -73.40% | -45.77% | -18.46% |
| Editas Medicine, Inc. (EDIT)vs › | $430.46M | -70.24% | -381.56% | -217.03% | -155.40% |
| NeoGenomics, Inc. (NEO)vs › | $429.88M | -6.60% | -10.82% | -11.36% | -7.59% |
| Prothena Corporation plc (PRTA)vs › | $420.34M | -15.33% | -56.08% | -39.28% | -33.86% |
| MapLight Therapeutics, Inc. (MPLT)vs › | $420.28M | -65.99% | -51.25% | -81.12% | -81.12% |
| Tectonic Therapeutic, Inc. (TECX)vs › | $436.92M | -38.32% | -35.34% | 12.60% | 10.50% |
| Assembly Biosciences, Inc. (ASMB)vs › | $438.56M | -0.01% | -61.70% | -96.25% | -81.28% |
| Senseonics Holdings, Inc. (SENS)vs › | $414.18M | -121.12% | 180.84% | -1331.02% | -839.91% |
| Strata Critical Medical, Inc. (SRTA)vs › | $412.28M | 14.40% | 1.26% | -7.83% | -9.02% |
ROE
-9.2%
ROA
-6.4%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-05-31 | -9.23% |
| 2026-02-28 | -118.53% |
| 2025-11-30 | -133.67% |
| 2025-08-31 | -142.06% |
| 2025-05-31 | -147.49% |
| 2025-02-28 | -34.38% |
| 2024-11-30 | -7.03% |
| 2024-08-31 | -6.14% |
| 2024-05-31 | -7.08% |
| 2024-02-29 | -9.38% |
| 2023-11-30 | -41.55% |
| 2023-08-31 | -41.94% |
| 2023-05-31 | -42.98% |
| 2023-02-28 | -51.47% |
| 2022-11-30 | -12.19% |
| 2022-08-31 | -10.85% |
| 2022-05-31 | -10.64% |
| 2022-02-28 | 1.16% |
| 2021-11-30 | -5.52% |
| 2021-08-31 | -5.83% |
| 2017-02-28 | 4.83% |
| 2016-11-30 | 3.34% |
| 2016-08-31 | 3.21% |
| 2016-05-31 | 1.95% |
| 2016-02-29 | -18.50% |
| 2015-11-30 | -67.40% |
| 2015-08-31 | -86.74% |
| 2015-05-31 | -70.99% |
| 2015-02-28 | -44.99% |
| 2014-08-31 | -84.63% |
| 2014-05-31 | -79.31% |
| 2014-02-28 | -29.77% |
| 2013-11-30 | -10.37% |
| 2013-08-31 | -16.29% |
| 2013-05-31 | -17.49% |
| 2013-02-28 | -21.66% |
| 2012-11-30 | -36.49% |
| 2012-08-31 | -29.36% |
